12:35 PM
 | 
Jan 12, 2018
 |  BC Extra  |  Company News

Roche's Ocrevus receives EU approval for MS

Roche (SIX:ROG; OTCQX:RHHBY) said the European Commission approved Ocrevus ocrelizumab to treat the relapsing and primary progressive forms of multiple sclerosis (PPMS)....

Read the full 89 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >